Browse by Journal

Harris, V. et al. (2025) Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial. Lancet Infectious Diseases, 25(1), pp. 68-79. (doi: 10.1016/S1473-3099(24)00431-6) (PMID:39265595)

Kaku, Y. et al. (2024) Virological characteristics of the SARS-CoV-2 KP.2 variant. Lancet Infectious Diseases, 24(7), e416. (doi: 10.1016/S1473-3099(24)00298-6) (PMID:38782005)

Cuomo-Dannenburg, G. et al. (2024) Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review. Lancet Infectious Diseases, 24(5), e307-e317. (doi: 10.1016/S1473-3099(23)00515-7) (PMID:38040006) (PMCID:PMC7615873)

Hampson, Katie ORCID: https://orcid.org/0000-0001-5392-6884 (2024) Good news for travellers, but what do rabies vaccines say about global health? Lancet Infectious Diseases, 24(2), pp. 119-121. (doi: 10.1016/S1473-3099(23)00499-1) (PMID:37802091)

Fornace, K. M. et al. (2023) Simian malaria: a narrative review on emergence, epidemiology and threat to global malaria elimination. Lancet Infectious Diseases, 23(12), E520-E520. (doi: 10.1016/S1473-3099(23)00298-0) (PMID:37454671)

Holdstock, V. et al. (2023) National case series of group A streptococcus pleural empyema in children: clinical and microbiological features. Lancet Infectious Diseases, 23(2), pp. 154-156. (doi: 10.1016/S1473-3099(23)00008-7) (PMID:36634683)

Florentino, P. T.V. et al. (2022) Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study. Lancet Infectious Diseases, 22(11), pp. 1577-1586. (doi: 10.1016/S1473-3099(22)00451-0) (PMID:35952702) (PMCID:PMC9359673)

Munro, A. P. S. et al. (2022) Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Lancet Infectious Diseases, 22(8), pp. 1131-1141. (doi: 10.1016/S1473-3099(22)00271-7) (PMID:35550261) (PMCID:PMC9084623)

Twohig, K. A. et al. (2022) Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study. Lancet Infectious Diseases, 22(1), pp. 35-42. (doi: 10.1016/S1473-3099(21)00475-8) (PMID:34461056) (PMCID:PMC8397301)

Hamilton, W. L. et al. (2021) Applying prospective genomic surveillance to support investigation of hospital-onset COVID-19. Lancet Infectious Diseases, 21(7), pp. 916-917. (doi: 10.1016/S1473-3099(21)00251-6) (PMID:33984262) (PMCID:PMC8110208)

MacLennan, J. M. et al. (2021) Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the United Kingdom – a cross-sectional, observational survey. Lancet Infectious Diseases, 21(5), pp. 677-687. (doi: 10.1016/S1473-3099(20)30842-2) (PMID:33482143)

Stresman, G. et al. (2020) Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data. Lancet Infectious Diseases, 20(8), pp. 953-963. (doi: 10.1016/S1473-3099(20)30059-1) (PMID:32277908) (PMCID:PMC7391005)

Akhvlediani, T. et al. (2020) Global outbreak research: harmony not hegemony. Lancet Infectious Diseases, 20(7), pp. 770-772. (doi: 10.1016/S1473-3099(20)30440-0) (PMID:32502433) (PMCID:PMC7266570)

Lindner, A. K. et al. (2020) New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice. Lancet Infectious Diseases, 20(2), e38-e46. (doi: 10.1016/S1473-3099(19)30612-7) (PMID:31879061)

Halliday, J. E.B. et al. (2020) Zoonotic causes of febrile illness in malaria endemic countries: a systematic review. Lancet Infectious Diseases, 20(2), e27-e37. (doi: 10.1016/S1473-3099(19)30629-2) (PMID:32006517) (PMCID:PMC7212085)

Grillet, M. E. et al. (2019) Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region. Lancet Infectious Diseases, 19(5), e149-e161. (doi: 10.1016/S1473-3099(18)30757-6) (PMID:30799251)

O'Sullivan, C. P. et al. (2019) Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014–15: a prospective surveillance study. Lancet Infectious Diseases, 19(1), pp. 83-90. (doi: 10.1016/S1473-3099(18)30555-3) (PMID:30497953)

WHO Rabies Modelling Consortium, et al. (2019) The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study. Lancet Infectious Diseases, 19(1), pp. 102-111. (doi: 10.1016/S1473-3099(18)30512-7) (PMID:30472178) (PMCID:PMC6300480)

Price, L. et al. (2018) Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income countries: a systematic review. Lancet Infectious Diseases, 18(5), e159-e171. (doi: 10.1016/S1473-3099(17)30479-6) (PMID:29100898)

Ma, Guangxu, Holland, Celia V., Wang, Tao, Hofmann, Andreas, Fan, Chia-Kwung, Maizels, Rick M. ORCID: https://orcid.org/0000-0003-3216-1944, Hotez, Peter J. and Gasser, Robin B. (2018) Human toxocariasis. Lancet Infectious Diseases, 18(1), e14-e24. (doi: 10.1016/S1473-3099(17)30331-6) (PMID:28781085)

Glynn, J. R. et al. (2017) Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infectious Diseases, 17(6), pp. 645-653. (doi: 10.1016/S1473-3099(17)30111-1) (PMID:28256310)

Scott, Janet T. ORCID: https://orcid.org/0000-0001-8030-5223 and Semple, Malcolm G. (2017) Ebola virus disease sequelae: a challenge that is not going away. Lancet Infectious Diseases, 17(5), pp. 470-471. (doi: 10.1016/S1473-3099(17)30027-0) (PMID:28094207) (PMCID:PMC5818139)

Burt, F. J. et al. (2017) Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infectious Diseases, 17(4), e107-e117. (doi: 10.1016/S1473-3099(16)30385-1) (PMID:28159534)

Mutapi, Frances, Maizels, Rick ORCID: https://orcid.org/0000-0003-3216-1944, Fenwick, Alan and Woolhouse, Mark (2017) Human schistosomiasis in the post Mass Drug Administration (MDA) era. Lancet Infectious Diseases, 17(2), e42-e48. (doi: 10.1016/S1473-3099(16)30475-3) (PMID:27988094)

Burki, Talha Khan, Crozier, Ian, Lado, Marta and Scott, Janet ORCID: https://orcid.org/0000-0001-8030-5223 (2016) Post-Ebola syndrome. Lancet Infectious Diseases, 16(7), pp. 780-781. (doi: 10.1016/S1473-3099(15)00259-5) (PMID:27352759)

Bar-Zeev, N. et al. (2015) Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infectious Diseases, 15(4), pp. 422-428. (doi: 10.1016/S1473-3099(14)71060-6) (PMID:25638521) (PMCID:PMC4374102)

Olsen, Jonathan R. ORCID: https://orcid.org/0000-0002-5356-8615, Gallacher, John, Finlay, Andrew Y., Piguet, Vincent and Francis, Nick A. (2015) Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. Lancet Infectious Diseases, 15(2), pp. 190-195. (doi: 10.1016/S1473-3099(14)71053-9)

Theodoratou, Evropi, McAllister, David A. ORCID: https://orcid.org/0000-0003-3550-1764, Reed, Craig, Adeloye, Davies O., Rudan, Igor, Muhe, Lulu M., Madhi, Shabir A., Campbell, Harry and Nair, Harish (2014) Global, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study. Lancet Infectious Diseases, 14(12), pp. 1250-1258. (doi: 10.1016/S1473-3099(14)70990-9) (PMID:25455992) (PMCID:PMC4242006)

Bustinduy, Amaya, King, Charles, Scott, Janet ORCID: https://orcid.org/0000-0001-8030-5223, Appleton, Sarah, Sousa-Figueiredo, José Carlos, Betson, Martha and Stothard, J. Russell (2014) HIV and schistosomiasis co-infection in African children. Lancet Infectious Diseases, 14(7), pp. 640-649. (doi: 10.1016/S1473-3099(14)70001-5) (PMID:24747019)

Halliday, Jo ORCID: https://orcid.org/0000-0002-1329-9035 (2013) Zoonoses in a changing world. Lancet Infectious Diseases, 13(2), p. 122. (doi: 10.1016/S1473-3099(13)70022-7)

Parkes-Ratanshi, Rosalind, Wakeham, Katie, Levin, Jonathan, Namusoke, Deodata, Whitworth, James, Coutinho, Alex, Mugisha, Nathan Kenya, Grosskurth, Heiner, Kamali, Anatoli and Lalloo, David G. (2011) Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infectious Diseases, 11(12), pp. 933-941. (doi: 10.1016/S1473-3099(11)70245-6) (PMID:21982529)

Thomson, E.C. ORCID: https://orcid.org/0000-0003-1482-0889 and Lynn, W.A. (2003) Septic thrombophlebitis with multiple pulmonary abscesses. Lancet Infectious Diseases, 3(2), p. 86. (doi: 10.1016/S1473-3099(03)00516-4)